Dr. Venkatesan most recently served as Chairman, President, and CEO of Angion Biomedica until its merger with Elicio Therapeutics in 2023. He currently serves as a Board Director at Elicio ...

Acres Farms, the vertical farming startup headquartered in Hamilton, announced Monday, Feb. 10, capital raises last year ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

Donald Trump Jr. and Eric Trump are participating in Dominari Holdings' private placement and are joining its advisory board.

DetraPel, Inc., a clean-tech advanced materials company, will relocate its headquarters and advanced manufacturing operations ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Valuation discrepancies in the biotech sector highlight Shuttle Pharma’s incredible potential. With several peer companies in ...

North Carolina life sciences companies, startups and academic institutions are tackling some of the world's greatest ...

Novartis is buying Anthos Therapeutics from Blackstone’s drug development division, as it makes a bet on an experimental drug aimed at preventing strokes in patients with an irregular heart rhythm.

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, primarily through its Enhaze platform. This technology, based on the rHuPH20 ...